News|Articles|February 12, 2018

Enhancing the Solubility of Poorly Soluble Drugs

External Link - PT1217 Dow-Brockhagen F&C pr3f-Web.pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Laine Mello Industry Outlook | Created with Canva

How Digitalization Is Transforming Pharmaceutical Manufacturing Processes

BySusan Haigney,Zachary Zubulake

January 27th 2026

US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities

ByChristopher Cole

January 27th 2026

Raj Puri Industry Outlook | Created with Canva

Navigating the Operational Tightrope in Pharmaceutical Manufacturing

BySusan Haigney,Zachary Zubulake

January 27th 2026

Pulmonologist doctor, lungs specialist. Aesthetic handdrawn highlighted illustration of human lings. Dark grey background, studio photo and collage. | Image Credit: ©mi_viri -stock.adobe.com

GSK’s RSV Vaccine Approved in Europe

BySusan Haigney

January 27th 2026

Mirum Acquires Bluejay | Created with Canva

Mirum Acquires Bluejay, Adding Brelovitug Treatment for HDV

ByZachary Zubulake

January 27th 2026

Enhancing the Solubility of Poorly Soluble Drugs

Newsletter

Related Content

How Digitalization Is Transforming Pharmaceutical Manufacturing Processes

US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities

Navigating the Operational Tightrope in Pharmaceutical Manufacturing

GSK’s RSV Vaccine Approved in Europe

Mirum Acquires Bluejay, Adding Brelovitug Treatment for HDV

Trending on Pharmaceutical Technology

US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities

GSK’s RSV Vaccine Approved in Europe

How Digitalization Is Transforming Pharmaceutical Manufacturing Processes

Mirum Acquires Bluejay, Adding Brelovitug Treatment for HDV

FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use